IL6 and congenital rubella syndrome: CRS is associated with elevated circulating levels of several cytokines including IL-6 and IFN-γ, and uncontrolled studies demonstrate that immunosuppression using tocilizumab, an anti-IL-6 receptor antibody, with or without corticosteroids can reverse the syndrome.